The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase

Katerina Leftheris, Gulzar Ahmed, Ran Chan, Alaric J. Dyckman, Zahid Hussain, Kan Ho, John Hynes, Jeffrey Letourneau, Wei Li, Shuqun Lin, Axel Metzger, Kevin J. Moriarty, Chris Riviello, Yvonne Shimshock, James Wen, John Wityak, Stephen T. Wrobleski, Hong Wu, Junjun Wu, Madhuri DesaiKathleen M. Gillooly, Tsung H. Lin, Derek Loo, Kim W. McIntyre, Sidney Pitt, Ding Ren Shen, David J. Shuster, Rosemary Zhang, David Diller, Arthur Doweyko, John Sack, Jack Baldwin, Joel Barrish, John Dodd, Ian Henderson, Steve Kanner, Gary L. Schieven, Maria Webb

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds